Comprehensive treatment for ROS1-overexpressed pulmonary sarcomatoid carcinoma: A case report.

ABSTRACT:

Key clinical message

In conclusion author highlights the tumor cell genetic testing or molecular pathological diagnosis plays a key role in the individualized treatment of PSC, which could benefit patients with advanced PSC.

Abstract

An uncommon form of non-small-cell lung cancer (NSCLC) with a poor prognosis is pulmonary sarcomatoid carcinoma (PSC). Surgical resection is currently the preferred treatment, but guidelines for adjuvant chemotherapy have not yet been established, especially for the advanced stage. The development of molecular subgroups in the field of tumors may be advantageous to advanced PSC patients with the ongoing progress of genomics and immunology. A 54-year-old man presented to Xishan People's Hospital of Wuxi City with recurrent intermittent dry cough

SUBMITTER: Sun W 

PROVIDER: S-EPMC10196425 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature